Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 14, 2013, Pages 1384-1393

  Stampalija, Tamara ^a,b,c,d   Romero, Roberto ^a   Korzeniewski, Steven J ^a,b   Chaemsaithong, Piya ^a,b   Miranda, Jezid ^a,b   Yeo, Lami ^a,b   Dong, Zhong ^a   Hassan, Sonia S ^a,b   Chaiworapongsa, Tinnakorn ^a,b  

^a HUTZEL HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Funisitis; IL 10; Inflammation; Intra amniotic infection inflammation; Preterm labor

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN SOLUBLE ST2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL INFLAMMATORY RESPONSE SYNDROME; FETUS DISEASE; FUNISITIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MATERNAL AGE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; RETROSPECTIVE STUDY; UMBILICAL CORD BLOOD;

ADULT; CHORIOAMNIONITIS; CROSS-SECTIONAL STUDIES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; PREGNANCY; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 84882400394     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.784258     Document Type: Article

References (203)

1. Romero R, Sirtori M, Oyarzun E, et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817-24 (Pubitemid 19252813)
2. Romero R, Mazor M, Wu YK, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12:262-79
3. Cherouny PH, Pankuch GA, Romero R, et al. Neutrophil attractant/ activating peptide-1/interleukin-8: Association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993;169:1299-303 (Pubitemid 24001655)
4. Romero R, Gomez R, Chaiworapongsa T, et al. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001;15:41-56 (Pubitemid 33719617)
5. Romero R, Brody DT, Oyarzun E, et al. Infection and labor. III. Interleukin-1: A signal for the onset of parturition. Am J Obstet Gynecol 1989;160:1117-23 (Pubitemid 19144470)
6. Newton ER. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol 2005;32:571-600 (Pubitemid 41111992)
7. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990;85:1392-400
8. Romero R, Sepulveda W, Kenney JS, et al. Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Found Symp 1992;167:205-20; discussion 203-20
9. Romero R, Manogue KR, Mitchell MD, et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:336-41
10. Bobitt JR, Hayslip CC, Damato JD. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor. Am J Obstet Gynecol 1981; 140:947-52 (Pubitemid 11061684)
11. Hameed C, Tejani N, Verma UL, Archbald F. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy. Am J Obstet Gynecol 1984;149:726-30 (Pubitemid 14054200)
12. Wahbeh CJ, Hill GB, Eden RD, Gall SA. Intra-amniotic bacterial colonization in premature labor. Am J Obstet Gynecol 1984;148: 739-43 (Pubitemid 14174316)
13. Leigh J, Garite TJ. Amniocentesis and the management of premature labor. Obstet Gynecol 1986;67:500-6 (Pubitemid 16116266)
14. Gravett MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986;67:229-37 (Pubitemid 16135569)
15. Skoll MA, Moretti ML, Sibai BM. The incidence of positive amniotic fluid cultures in patients preterm labor with intact membranes. Am J Obstet Gynecol 1989;161:813-16 (Pubitemid 19252812)
16. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79: 351-7
17. Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805-16 (Pubitemid 23317510)
18. Coultrip LL, Lien JM, Gomez R, et al. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1994;171:901-11 (Pubitemid 24341467)
19. Yoon BH, Yang SH, Jun JK, et al. Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: A comparison with amniotic fluid white blood cell count. Obstet Gynecol 1996;87:231-37 (Pubitemid 26033138)
20. Markenson GR, Martin RK, Tillotson-Criss M, et al. The use of the polymerase chain reaction to detect bacteria in amniotic fluid in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1997;177:1471-7 (Pubitemid 28040245)
21. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202 (Pubitemid 28394495)
22. Kara M, Ozden S, Arioglu P, Cetin A. The significance of amniotic fluid interleukin-6 levels in preterm labour. Aust N Z J Obstet Gynaecol 1998;38:403-6 (Pubitemid 28542422)
23. Greci LS, Gilson GJ, Nevils B, et al. Is amniotic fluid analysis the key to preterm labor? A model using interleukin-6 for predicting rapid delivery. Am J Obstet Gynecol 1998;179:172-8 (Pubitemid 28394492)
24. Yoon BH, Chang JW, Romero R. Isolation of Ureaplasma urealyticum from the amniotic cavity and adverse outcome in preterm labor. Obstet Gynecol 1998;92:77-82 (Pubitemid 28285325)
25. Gonzalez-Bosquet E, Cerqueira MJ, Dominguez C, et al. Amniotic fluid glucose and cytokines values in the early diagnosis of amniotic infection in patients with preterm labor and intact membranes. J Matern Fetal Med 1999;8:155-8 (Pubitemid 29297278)
26. Locksmith GJ, Clark P, Duff P, Schultz GS. Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection. Obstet Gynecol 1999;94:1-6 (Pubitemid 29284416)
27. Rizzo G, Capponi A, Vlachopoulou A, et al. Ultrasonographic assessment of the uterine cervix and interleukin-8 concentrations in cervical secretions predict intrauterine infection in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol 1998;12:86-92 (Pubitemid 28432875)
28. Romero R, Quintero R, Oyarzun E, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;159:661-6
29. Cotton DB, Hill LM, Strassner HT, et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984; 63:38-43 (Pubitemid 14221916)
30. Broekhuizen FF, Gilman M, Hamilton PR. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol 1985;66:316-21 (Pubitemid 15016565)
31. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol 1986;67:579-83 (Pubitemid 16116281)
32. Feinstein SJ, Vintzileos AM, Lodeiro JG, et al. Amniocentesis with premature rupture of membranes. Obstet Gynecol 1986;68: 147-52 (Pubitemid 16038606)
33. Garite TJ, Freeman RK, Linzey EM, Braly P. The use of amniocentesis in patients with premature rupture of membranes. Obstet Gynecol 1979;54:226-30 (Pubitemid 9206157)
34. Gauthier DW, Meyer WJ. Comparison of gram stain, leukocyte esterase activity, and amniotic fluid glucose concentration in predicting amniotic fluid culture results in preterm premature rupture of membranes. Am J Obstet Gynecol 1992;167:1092-5
35. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839-51 (Pubitemid 23317515)
36. Font GE, Gauthier DW, Meyer WJ, et al. Catalase activity as a predictor of amniotic fluid culture results in preterm labor or premature rupture of membranes. Obstet Gynecol 1995;85: 656-8
37. Hussey MJ, Levy ES, Pombar X, et al. Evaluating rapid diagnostic tests of intra-amniotic infection: Gram stain, amniotic fluid glucose level, and amniotic fluid to serum glucose level ratio. Am J Obstet Gynecol 1998;179:650-6 (Pubitemid 28447241)
38. Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000;183: 1130-7
39. Gomez R, Romero R, Nien JK, et al. A short cervix in women with preterm labor and intact membranes: A risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2005;192: 678-89 (Pubitemid 40311256)
40. Hassan S, Romero R, Hendler I, et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006;34:13-9 (Pubitemid 43106293)
41. Vaisbuch E, Romero R, Mazaki-Tovi S, et al. The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester. Am J Obstet Gynecol 2010; 203:446 e441-9
42. Vaisbuch E, Hassan SS, Mazaki-Tovi S, et al. Patients with an asymptomatic short cervix (5or15 mm) have a high rate of subclinical intraamniotic inflammation: Implications for patient counseling. Am J Obstet Gynecol 2010;202:433 e431-8
43. Romero R, Gonzalez R, Sepulveda W, et al. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: Prevalence and clinical significance. Am J Obstet Gynecol 1992;167:1086-91
44. Lee SE, Romero R, Park CW, et al. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am J Obstet Gynecol 2008;198:633 e631-8
45. Kim SK, Romero R, Kusanovic JP, et al. The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med 2010;38:45-53
46. Gomez R, Romero R, Nien JK, et al. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005;18:31-7 (Pubitemid 41224360)
47. Madan I, Romero R, Kusanovic JP, et al. The frequency and clinical significance of intra-amniotic infection and/or inflammation in women with placenta previa and vaginal bleeding: An unexpected observation. J Perinat Med 2010;38:275-9
48. Carroll SG, Papaioannou S, Ntumazah IL, et al. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1996; 103:54-9 (Pubitemid 26009924)
49. Ferrazzi E, Muggiasca ML, Fabbri E, et al. Assessment of fetal inflammatory syndrome by ''classical'' markers in the management of preterm labor: A possible lesson from metabolomics and system biology. J Matern Fetal Neonatal Med 2012;25:54-61
50. Novy MJ, Duffy L, Axthelm MK, et al. Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci 2009;16:56-70
51. Carroll SG, Papioannou S, Ntumazah IL, Philpott-Howard J, Nicolaides KH. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1996;103:54-9 (Pubitemid 26009924)
52. Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, Carlo WA, Hauth JC. The Alabama Preterm Birth Study: Umbilical cord Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm new born infants. Am J Obstet Gynecol 2008;198:43.e1-5
53. Romero R, Garite TJ. Twenty percent of very preterm neonates (23-32 weeks of gestation) are born with bacteremia caused by genital mycoplasmas. Am J Obstet Gynecol 2008;198:1-3 (Pubitemid 350309292)
54. Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007;50:652-83 (Pubitemid 47357241)
55. Yoon BH, Romero R, Park JS, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000;183:1124-9
56. Murthy V, Kennea NL. Antenatal infection/inflammation and fetal tissue injury. Best Pract Res Clin Obstet Gynaecol 2007;21:479-89 (Pubitemid 46830372)
57. Kim CJ, Yoon BH, Park SS, et al. Acute funisitis of preterm but not term placentas is associated with severe fetal inflammatory response. Hum Pathol 2001;32:623-9 (Pubitemid 32601244)
58. Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: The histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25
59. Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93 (Pubitemid 28394494)
60. Arad I, Ergaz Z. The fetal inflammatory response syndrome and associated infant morbidity. Isr Med Assoc J 2004;6:766-9 (Pubitemid 39646693)
61. Kim YM, Romero R, Chaiworapongsa T, et al. Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Toll-like receptors in epidermal keratinocytes. Histopathology 2006;49:506-14 (Pubitemid 44631624)
62. Zhang L, Saito M, Jobe A, et al. Intra-amniotic administration of E coli lipopolysaccharides causes sustained inflammation of the fetal skin in sheep. Reprod Sci 2012;19:1181-9
63. Kemp MW, Saito M, Kallapur SG, et al. Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum. Reprod Sci 2011;18:1128-37
64. Romero R, Espinoza J, Goncalves LF, et al. Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2004;16:146-57 (Pubitemid 40006901)
65. Letti Muller AL, Barrios Pde M, Kliemann LM, et al. Tei index to assess fetal cardiac performance in fetuses at risk for fetal inflammatory response syndrome. Ultrasound Obstet Gynecol 2010;36:26-31
66. Yanowitz TD, Jordan JA, Gilmour CH, et al. Hemodynamic disturbances in premature infants born after chorioamnionitis: Association with cord blood cytokine concentrations. Pediatr Res 2002;51:310-16 (Pubitemid 34174966)
67. Yoon BH, Romero R, Kim KS, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-9 (Pubitemid 29503589)
68. Mittendorf R, Covert R, Montag AG, et al. Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates. J Perinat Med 2005;33:428-34 (Pubitemid 41306458)
69. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001;79:205-9 (Pubitemid 32247087)
70. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-15 (Pubitemid 26049651)
71. Jobe AH. Antenatal associations with lung maturation and infection. J Perinatol 2005;25:S31-5 (Pubitemid 40862223)
72. Ghezzi F, Gomez R, Romero R, et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998;78:5-10 (Pubitemid 28186855)
73. Jobe AH, Newnham JP, Willet KE, et al. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am J Obstet Gynecol 2000;182:401-8 (Pubitemid 30127355)
74. Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997;99:2992-9 (Pubitemid 27278676)
75. Sood BG, Madan A, Saha S, et al. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 2010;67:394-400
76. Yoon BH, Kim YA, Romero R, et al. Association of oligohydramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1999;181:784-8 (Pubitemid 29503591)
77. Yoon BH, Romero R, Jun JK, et al. An increase in fetal plasma cortisol but not dehydroepiandrosterone sulfate is followed by the onset of preterm labor in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol 1998;179:1107-14 (Pubitemid 28533754)
78. Romero R, Savasan ZA, Chaiworapongsa T, et al. Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med 2011;40:19-32
79. Berry SM, Romero R, Gomez R, et al. Premature parturition is characterized by in utero activation of the fetal immune system. Am J Obstet Gynecol 1995;173:1315-20
80. Chaiworapongsa T, Romero R, Berry SM, et al. The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome. J Perinat Med 2011; 39:653-66
81. De Felice C, Toti P, Santopietro R, et al. Small thymus in very low birth weight infants born to mothers with subclinical chorioamnionitis. J Pediatr 1999;135:384-6 (Pubitemid 30180517)
82. Toti P, De Felice C, Stumpo M, et al. Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum Pathol 2000;31: 1121-8
83. Di Naro E, Cromi A, Ghezzi F, et al. Fetal thymic involution: A sonographic marker of the fetal inflammatory response syndrome. Am J Obstet Gynecol 2006;194:153-9 (Pubitemid 43017790)
84. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182: 675-81 (Pubitemid 30207333)
85. Andrews WW, Cliver SP, Biasini F, et al. Early preterm birth: Association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol 2008;198:466.e1-11
86. Mittendorf R, Montag AG, MacMillan W, et al. Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol 2003;188:1438-4
87. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-40 (Pubitemid 26165257)
88. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8 (Pubitemid 27276750)
89. Leviton A, Paneth N, Reuss ML, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999;46:566-75 (Pubitemid 29496486)
90. Patrick LA, Smith GN. Proinflammatory cytokines: A link between chorioamnionitis and fetal brain injury. J Obstet Gynaecol Can 2002;24:705-9
91. Hagberg H, Mallard C, Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG 2005;112:16-18 (Pubitemid 40313975)
92. Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: A review. J Perinat Med 2006; 34:5-12 (Pubitemid 43106292)
93. Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 2003;110:124-7 (Pubitemid 36577401)
94. Elovitz MA, Brown AG, Breen K, et al. Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 2011;29:663-71
95. Moon JB, Kim JC, Yoon BH, et al. Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy. J Perinat Med 2002;30:301-6 (Pubitemid 34976468)
96. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26 (Pubitemid 27327305)
97. Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-11 (Pubitemid 27385721)
98. Gabrielli L, Bonasoni MP, Lazzarotto T, et al. Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 2009;46:S16-21
99. Cardenas I, Mor G, Aldo P, et al. Placental viral infection sensitizes to endotoxin-induced pre-term labor: A double hit hypothesis. Am J Reprod Immunol 2011;65:110-17
100. Cardenas I, Means RE, Aldo P, et al. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 2010;185: 1248-57
101. McCarthy M, Auger D, Whittemore SR. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J Hum Virol 2000;3:215-28
102. Von Herzen JL, Benirschke K. Unexpected disseminated herpes simplex infection in a newborn. Obstet Gynecol 1977;50: 728-30 (Pubitemid 8237059)
103. Hyde SR, Giacoia GP. Congenital herpes infection: Placental and umbilical cord findings. Obstet Gynecol 1993;81:852-5 (Pubitemid 23139011)
104. Heifetz SA, Bauman M. Necrotizing funisitis and herpes simplex infection of placental and decidual tissues: Study of four cases. Hum Pathol 1994;25:715-22 (Pubitemid 24230751)
105. Vaisbuch E, Romero R, Gomez R, et al. An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: Implications for the understanding of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2011;24:391-6
106. Bhatia M, He M, Zhang H, Moochhala S. Sepsis as a model of SIRS. Front Biosci 2009;14:4703-11
107. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007;38:1336-45 (Pubitemid 350192404)
108. Carden DL, Granger DN. Pathophysiology of ischaemiareperfusion injury. J Pathol 2000;190:255-66
109. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996;32:743-51 (Pubitemid 26332313)
110. Franco-Pons N, Casas J, Fabrias G, et al. Fat necrosis generates proinflammatory halogenated lipids during acute pancreatitis. Ann Surg 2012;Sept 7 e-pub ahead of print
111. Eming SA, Hammerschmidt M, Krieg T, Roers A. Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol 2009;20:517-27
112. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105:S13-33
113. Matzinger P. The danger model: A renewed sense of self. Science 2002;296:301-5 (Pubitemid 34303674)
114. Hashimoto C, Hudson KL, Anderson KV. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988;52:269-79
115. Medzhitov R, Janeway Jr C,. The Toll receptor family and microbial recognition. Trends Microbiol 2000;8:452-6
116. Hargreaves DC, Medzhitov R. Innate sensors of microbial infection. J Clin Immunol 2005;25:503-10 (Pubitemid 43011742)
117. Pasare C, Medzhitov R. Toll-like receptors: Linking innate and adaptive immunity. Microbes Infect 2004;6:1382-7 (Pubitemid 41110581)
118. Castellheim A, Brekke OL, Espevik T, et al. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 2009;69:479-91
119. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: Understanding the role of innate and acquired immunity. Shock 2001;16:83-96 (Pubitemid 33596740)
120. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: The Toll-like receptors and their transducers. J Leukoc Biol 2003;74:479-85 (Pubitemid 38040374)
121. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365:63-78
122. Beutler B, Poltorak A. Sepsis and evolution of the innate immune response. Crit Care Med 2001;29:S2-6; discussion S6-7
123. Beutler B. Science review: Key inflammatory and stress pathways in critical illness - the central role of the Toll-like receptors. Crit Care 2003;7:39-46 (Pubitemid 36204268)
124. Beutler B, Cerami A. Cachectin/tumor necrosis factor: An endogenous mediator of shock and inflammation. Immunol Res 1986;5:281-93 (Pubitemid 17059101)
125. Beutler B. Innate immune sensing of microbial infection: The mechanism and the therapeutic challenge. Wien Med Wochenschr 2002;152:547-51 (Pubitemid 35440777)
126. Keel M, Ungethum U, Steckholzer U, et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997;90: 3356-63 (Pubitemid 27473403)
127. Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997;42:863-70; discussion 870-61
128. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011;29: 71-109
129. Scumpia PO, Moldawer LL. Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 2005;33: S468-71 (Pubitemid 41785991)
130. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22
131. Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol 1993;11:165-90 (Pubitemid 23115005)
132. Fagundes CT, Amaral FA, Souza AL, et al. ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol 2007;81:492-9 (Pubitemid 46198401)
133. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsisinduced immunosuppression: From bad to worse. Immunol Res 2001;24:273-87
134. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 1989;258:301-04 (Pubitemid 20001074)
135. Takagi T, Yanagisawa K, Tsukamoto T, et al. Identification of the product of the murine ST2 gene. Biochim Biophys Acta 1993; 1178:194-200 (Pubitemid 23247998)
136. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin- 1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90 (Pubitemid 41587888)
137. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007;179:2051-4
138. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009;113:1526-34
139. Bourgeois E, Van LP, Samson M, et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009;39:1046-55
140. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998;187:787-94 (Pubitemid 28115194)
141. Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998;95:6930-5 (Pubitemid 28278084)
142. Coyle AJ, Lloyd C, Tian J, et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999;190:895-902 (Pubitemid 29480818)
143. Townsend MJ, Fallon PG, Matthews DJ, et al. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000;191: 1069-76
144. Leung BP, Xu D, Culshaw S, et al. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 2004; 173:145-50 (Pubitemid 38797335)
145. Sweet MJ, Leung BP, Kang D, et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001;166:6633-9 (Pubitemid 32467204)
146. Brint EK, Xu D, Liu H, et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004;5:373-79 (Pubitemid 38500085)
147. Saccani S, Polentarutti N, Penton-Rol G, et al. Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 1998;10: 773-80 (Pubitemid 28495228)
148. Mildner M, Storka A, Lichtenauer M, et al. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res 2010;87:769-77
149. Kumar S, Tzimas MN, Griswold DE, Young PR. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun 1997; 235:474-8 (Pubitemid 27326503)
150. Granne I, Southcombe JH, Snider JV, et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One 2011;6:e24463
151. Stampalija T CT, Chaemsaithong P, Korzeniewski S, et al. Maternal plasma concentrations of sST2 and angiogenic/ anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med (in press).
152. Stampalija T CT, Romero R, Tarca AL, et al. Soluble ST2, a modulator of the inflammatory response, in preterm and term labor. J Matern Fetal Neonatal Med (submitted).
153. Topping V, Romero R, Than NG, et al. Interleukin-33 in the human placenta. J Matern Fetal Neonatal Med 2013;26:327-38
154. Savasan ZA, Chaiworapongsa T, Romero R, et al. Interleukin-19 in fetal systemic inflammation. J Matern Fetal Neonatal Med 2012;25:995-1005
155. Liu J, Buckley JM, Redmond HP, Wang JH. ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance. J Immunol 2010;184:5802-8
156. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003;117:re3
157. O'Neill LA, Dinarello CA. The IL-1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense. Immunol Today 2000;21:206-9 (Pubitemid 30259023)
158. Brint EK, Fitzgerald KA, Smith P, et al. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction. J Biol Chem 2002;277:49205-11 (Pubitemid 36014349)
159. Buckley JM, Liu JH, Li CH, et al. Increased susceptibility of ST2-deficient mice to polymicrobial sepsis is associated with an impaired bactericidal function. J Immunol 2011;187: 4293-9
160. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765 (Pubitemid 32368050)
161. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 2007;204:239-43 (Pubitemid 46294539)
162. Li C, Corraliza I, Langhorne J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun 1999;67:4435-42 (Pubitemid 29400417)
163. Deckert M, Soltek S, Geginat G, et al. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect Immun 2001;69:4561-71 (Pubitemid 32574458)
164. Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4 T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996;157:798-805 (Pubitemid 26231385)
165. Hunter CA, Ellis-Neyes LA, Slifer T, et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 1997;158:3311-16 (Pubitemid 127484048)
166. Nylen S, Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 2007;28:378-84 (Pubitemid 47385375)
167. Lilic D, Gravenor I, Robson N, et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immun 2003;71:5690-9 (Pubitemid 37205622)
168. Mancilla-Diaz JM, Escartin-Perez RE, Lopez-Alonso VE, et al. Role of 5-HT1A and 5-HT1B receptors in the hypophagic effect of 5-HT on the structure of feeding behavior. Med Sci Monit 2005; 11:BR74-9
169. Pagliari C, Fernandes ER, Guedes F, et al. Role of mast cells as IL10 producing cells in paracoccidioidomycosis skin lesions. Mycopathologia 2006;162:331-5 (Pubitemid 44819316)
170. Fornari MC, Bava AJ, Guereno MT, et al. High serum interleukin-10 and tumor necrosis factor alpha levels in chronic paracoccidioidomycosis. Clin Diagn Lab Immunol 2001;8: 1036-8 (Pubitemid 32868330)
171. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177: 1205-8 (Pubitemid 23097411)
172. Lang R, Rutschman RL, Greaves DR, Murray PJ. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J Immunol 2002;168:3402-11 (Pubitemid 34250404)
173. Jankovic D, Trinchieri G. IL-10 or not IL-10: That is the question. Nat Immunol 2007;8:1281-3 (Pubitemid 350131163)
174. Fitzgerald DC, Zhang GX, El-Behi M, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007;8:1372-9 (Pubitemid 350131174)
175. Awasthi A, Carrier Y, Peron JP, et al. A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells. Nat Immunol 2007;8:1380-9 (Pubitemid 350131175)
176. Stumhofer JS, Silver JS, Laurence A, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007;8:1363-71 (Pubitemid 350131173)
177. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007;8:1390-97 (Pubitemid 350138974)
178. Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 2006;6:379-86
179. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51
180. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95
181. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55
182. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20
183. Willems F, Marchant A, Delville JP, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994;24:1007-9 (Pubitemid 24093803)
184. Sakaguchi S. Naturally arising CD4 regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-62 (Pubitemid 38680433)
185. Yoon BH, Romero R, Shim JY, et al. C-reactive protein in umbilical cord blood: A simple and widely available clinical method to assess the risk of amniotic fluid infection and funisitis. J Matern Fetal Neonatal Med 2003;14:85-90 (Pubitemid 37011674)
186. Santana C, Guindeo MC, Gonzalez G, et al. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr 2001;90:1176-81 (Pubitemid 32964495)
187. Nishimaki S, Sato M, An H, et al. Comparison of markers for fetal inflammatory response syndrome: Fetal blood interleukin-6 and neonatal urinary beta(2)-microglobulin. J Obstet Gynaecol Res 2009;35:472-6
188. Romero R, Gomez R, Galasso M, et al. The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: The effect of gestational age, fetal gender, and intrauterine infection. Am J Obstet Gynecol 1994;171:912-21 (Pubitemid 24341468)
189. Romero R, Ceska M, Avila C, et al. Neutrophil attractant/ activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991;165:813-20
190. Paananen R, Husa AK, Vuolteenaho R, et al. Blood cytokines during the perinatal period in very preterm infants: Relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009;154:39-43 e33
191. Chaiworapongsa T, Romero R, Kim JC, et al. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol 2002;186:1178-82 (Pubitemid 34665056)
192. Savasan ZA, Chaiworapongsa T, Romero R, et al. Interleukin-19 in fetal systemic inflammation. J Matern Fetal Neonatal Med 2012;25:995-1005
193. Wirbelauer J, Seidenspinner S, Thomas W, et al. Funisitis is associated with increased interleukin-10 gene expression in cord blood mononuclear cells in preterm infants 5/32 weeks of gestation. Eur J Obstet Gynecol Reprod Biol 2011;155:31-5
194. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006;177:4888-96 (Pubitemid 44469825)
195. Terrone DA, Rinehart BK, Granger JP, et al. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001;98:476-80
196. Fortunato SJ, Menon R, Swan KF, Lombardi SJ. Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: Transcriptional regulation. Am J Obstet Gynecol 1996;175: 1057-65 (Pubitemid 26357983)
197. Froen JF, Munkeby BH, Stray-Pedersen B, Saugstad OD. Interleukin-10 reverses acute detrimental effects of endotoxininduced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res 2002;942:87-94 (Pubitemid 34597072)
198. Meyer U, Murray PJ, Urwyler A, et al. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 2008;13:208-21
199. Brunner M, Krenn C, Roth G, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 2004;30:1468-73 (Pubitemid 38951733)
200. Hoogerwerf JJ, Tanck MW, van Zoelen MA, et al. Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med 2010;36:630-7
201. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50 (Pubitemid 36056721)
202. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008;8:32-43
203. Volk HD, Reinke P, Docke WD. Clinical aspects: From systemic inflammation to 'immunoparalysis'. Chem Immunol 2000;74: 162-77